RACA · Categories · Form 4
RACA - SEC Form 4 insider transactions
Therapeutics Acquisition Corp. (RACA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for RACA
- SEC Form 4 filed by Lubner David Charles4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Malik Rajesh4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by MARGOLIN YAEL4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by GOTTLIEB MICHAEL M.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by HOGUE GERALD L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by FLESHNER NEIL E.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by DEMERS WILLIAM L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by GILMOUR MARGARET E.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by JENSEN JESSICA D.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by GOODMAN JONATHAN R.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: GOTTLIEB MICHAEL M. was granted 1,156,887 units of Common Stock4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by HOGUE GERALD L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by JENSEN JESSICA D.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: MCCANN JOE A. was granted 3,614,153 units of Common Stock4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: SILBER ALLAN C was granted 8,864,091 units of Common Stock4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by DEMERS WILLIAM L.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: FLESHNER NEIL E. was granted 3,820,778 units of Common Stock4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4 filed by Therapeutics Acquisition Corp.4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: GOODMAN JONATHAN R. was granted 57,395 units of Common Stock4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
- SEC Form 4: RA CAPITAL MANAGEMENT, L.P. bought $2,091,000 worth of Common Stock (209,100 units at $10.00)4 - Therapeutics Acquisition Corp. (0001811764) (Issuer)
- SEC Form 4: Kolchinsky Peter was granted 209,100 units of Common Stock4 - Therapeutics Acquisition Corp. (0001811764) (Issuer)
- SEC Form 4: Kolchinsky Peter was granted 889,218 units of Common Stock4 - Therapeutics Acquisition Corp. (0001811764) (Issuer)